INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

2,768 studies · page 5 of 116

2021 / Pragmatic, multicentre, 2 x 2 factorial randomized controlled trial

Progressive exercise and corticosteroid injections were not superior to best practice advice or no injection for rotator cuff disorders over 12 months.

A 2 x 2 factorial trial compared progressive exercise (up to 6 sessions) against a single best practice advice session, with or without corticosteroid injection, in 708 adults with rotator cuff disorders. Over 12 months, no evidence of a difference in SPADI score was found between progressive exercise and best practice advice (adjusted mean difference -0.66 [99% CI -4.52 to 3.20]). Similarly, no difference was observed between corticosteroid injection and no injection (adjusted mean difference -1.11 [99% CI -4.47 to 2.26]). No serious adverse events were reported.

Hopewell S, Keene DJ, Marian IR, et al. Lancet, 2021. PMID 34265255

2021 / Randomized open-label controlled trial

Melissa officinalis tea reduced 24-hour premature ventricular beats, triglycerides, total cholesterol, and fasting blood sugar in patients with PVCs.

A 12-week randomized trial examined the effects of Melissa officinalis (MO) tea (2 g dried leaves twice daily plus lifestyle recommendations) compared to lifestyle recommendations alone in 60 patients with PVCs. Patients receiving MO tea had significantly lower adjusted mean 24-hour premature ventricular beats (2142.39 vs. 3126.05; P = .017). They also showed significantly lower adjusted means for triglycerides (144.75 vs. 174.27 mg/dL), total cholesterol (155.35 vs. 171.99 mg/dL), and fasting blood sugar (90.85 vs. 99.84 mg/dL; P <= .042). The intervention did not significantly affect LDL-C or HDL-C levels.

Kheirkhah J, Ghorbani Z, Salari A, et al. Int J Clin Pract, 2021. PMID 34309987

2021 / Controlled trial

Cold water immersion provided no functional or perceptual benefits compared to a sham intervention during a lower body resistance training program.

Thirteen resistance-trained men were allocated to either cold water immersion (CWI; 10 minutes at 10°C) or a sham intervention immediately following each session of a 2 x 4-week lower body resistance training program (16 total sessions). The training program led to significant increases in muscle fibre pennation angle (p = 0.009), isometric peak force (p = 0.018), and 1/4 squat (p < 0.001), with no differences between groups (all p > 0.05). Perceptual responses also did not differ between groups. CWI demonstrated no functional or perceptual benefits over the sham intervention, and showed no detrimental impact on morphological adaptations.

Wilson LJ, Dimitriou L, Hills FA, et al. J Strength Cond Res, 2021. PMID 34324460

2021 / Randomized placebo-controlled triple-blind clinical trial

Garlic tablet supplementation significantly reduced endometriosis-related pain compared to placebo over three months.

In a triple-blind trial, 60 women with endometriosis were randomly assigned to receive usual care plus either 400 mg garlic tablets or identical placebo tablets for three months. Pain was measured before intervention and at one-, two-, and three-month follow-ups using a four-part VAS. The overall severity of pain decreased from 6.51 ± 0.86 to 1.83 ± 1.25 in the garlic group (p < 0.05), but increased from 6.41 ± 1.12 to 6.65 ± 1.37 in the control group (p = 0.02). Repeated measures ANOVA demonstrated a significant difference in pain score changes between the groups (p < 0.001, np2 = 0.572).

Amirsalari S, Behboodi Moghadam Z, Taghizadeh Z, et al. Evid Based Complement Alternat Med, 2021. PMID 34335819

2021 / 16-week, double-blind, randomized, placebo-controlled trial

In pre-frail and frail older adults, protein, leucine, or creatine supplements did not enhance the benefits of resistance training on muscle mass or function.

A 16-week, double-blind, randomized, placebo-controlled trial investigated whether nutritional supplements enhance adaptations to twice-weekly resistance training in 200 pre-frail and frail elderly individuals. Across four sub-investigations, leucine supplementation was ineffective for improving muscle mass and function, and whey, soy, or creatine (alone or combined) failed to enhance resistance training adaptations. Furthermore, no sex-based differences were observed in response to whey. Resistance exercise alone increased muscle mass and function in all sub-investigations, and no adverse effects were reported.

Roschel H, Hayashi AP, Fernandes AL, et al. Clin Nutr, 2021. PMID 34358827

2021 / Randomized, double-blind, placebo-controlled trial

In mild to moderate Alzheimer's disease, 52 weeks of trans-resveratrol decreased CSF MMP-9 by 46% and reduced brain volume compared to placebo.

Thirty patients with moderate to mild Alzheimer's disease were randomized to receive 500 mg trans-resveratrol orally once daily or placebo for 52 weeks. Trans-resveratrol did not lead to statistically significant changes in blood or CSF Aβ40, whereas placebo participants showed significant decreases in CSF (P = 0.024) and plasma Aβ40 (P = 0.036). Compared with placebo, trans-resveratrol resulted in a significant reduction in brain volume at 52 weeks (P = 0.011) and a 46% decrease in CSF matrix metallopeptidase 9 (P = 0.033).

Gu J, Li Z, Chen H, et al. Neurol Ther, 2021. PMID 34402024

2021 / Randomized triple-blind placebo-controlled clinical trial

A 300-mg dose of caffeine did not significantly alter tinnitus-related discomfort or psychoacoustic and electroacoustic measures in chronic tinnitus patients.

Eighty patients with chronic tinnitus followed a 24-hour caffeine-restricted diet and were randomized to receive either a 300-mg caffeine capsule or a placebo (cornstarch). Assessments were performed at baseline and after capsule ingestion using questionnaires (THI, VAS, POMS) and audiometric and otoacoustic evaluations (TEOAE, DPOAE). A significant change in mood (POMS) occurred after caffeine consumption, while THI and VAS scores improved at the second timepoint in both groups. Differences in some audiometry frequencies and otoacoustic measures between baseline and follow-up occurred in both groups but were not clinically relevant, showing that 300 mg of caffeine did not significantly alter tinnitus-related discomfort.

Ledesma ALL, Leite Rodrigues D, Monteiro de Castro Silva I, et al. PLoS One, 2021. PMID 34543285

2021 / Randomized, double-blind, placebo-controlled trial

Yellow maca treatment did not significantly improve sperm concentration or hormones compared to placebo in infertile patients, except for reduced free testosterone.

A 16-week randomized, double-blind, placebo-controlled trial examined the effects of yellow maca (Lepidium meyenii Walpers) in 50 patients with reproductive-related problems. Maca treatment increased sperm concentration by 40% compared to a 76% increase with placebo after 8 and 16 weeks, but the difference was statistically non-significant. No statistically significant changes were observed in hormone levels with maca, aside from a decrease in free testosterone. The authors concluded that the results are insufficient to determine the efficacy of maca on male fertility.

Melnikovova I, Russo D, Fait T, et al. Phytother Res, 2021. PMID 34585449

2021 / Randomized, double-blind, placebo-controlled clinical trial

Wheat germ capsules significantly reduced severe postpartum pain and mefenamic acid use compared to placebo.

A randomized, double-blind, placebo-controlled trial evaluated the effect of 500 mg wheat germ capsules taken every 6 hours for 2 days versus placebo in 90 women with moderate to severe postpartum pain. Postpartum pain in women with moderate pain decreased in both groups, with a non-significant greater reduction in the wheat germ group (GEE=0.04). In women with severe pain, the reduction was significantly greater in the wheat germ group compared to placebo (GEE=0.63, p=0.007). In addition, mefenamic acid use was significantly lower in the wheat germ group (p=0.04), and no side effects were reported.

Mehravar S, Amir Ali Akbari S, Nasiri M, et al. Avicenna J Phytomed, 2021. PMID 34804895

2021 / Open-labeled noncontrolled clinical trial

In patients with knee osteoarthritis, 500 mg/day of resveratrol for 90 days improved aggrecan levels, pain, and KOOS scores, but not Coll 2-1.

An open-labeled noncontrolled clinical trial evaluated the effect of 500 mg/day oral resveratrol monotherapy for 90 days in knee osteoarthritis patients. Resveratrol administration led to a nonsignificant decrease in serum Coll 2-1 and a significant increase in serum aggrecan. Pain scores measured by VAS and KOOS significantly improved after 30 days, alongside significant improvements in all KOOS subscale areas that persisted through three months.

Marouf BH Biomed Res Int, 2021. PMID 34805399

2021 / Randomized placebo-controlled parallel-arm trial

Daily vinegar ingestion improved depression scores and altered urinary metabolites in healthy college students over four weeks.

In a 4-week placebo-controlled parallel trial, healthy college students were randomized to daily liquid vinegar (1.5 g acetic acid/day; n = 14) or a control pill (0.015 g acetic acid/day; n = 11) with no changes to diet or physical activity. At week four, the change in both POMS depression scores and CES-D scores differed significantly between groups, favoring improved affect in the vinegar group compared to control. Targeted metabolomics indicated metabolite alterations linked to vinegar ingestion, including enzymatic dysfunction in the hexosamine pathway and significant increases in glycine, serine, and threonine metabolism.

Johnston CS, Jasbi P, Jin Y, et al. Nutrients, 2021. PMID 34836275

2020 / Staggered multiple baseline intervention trial

A community-delivered exercise and behavioral intervention improved physical activity and quality of life in persons with dementia and caregiver depression.

A 6-week in-home multicomponent program combining exercise with behavioral/psychosocial training was translated into community delivery by Area Agencies on Aging case managers. Among 255 enrolled dyads, 207 completed the intervention and 140 completed a 13-month follow-up. Persons with dementia had significant increases in physical activity from pre- to posttreatment (p < .001, ES = .54) and at 13 months (p < .01, ES = .21), as well as increased quality of life pre- to posttreatment (p < .001, ES = .29). Caregiver depression also improved from pre- to posttreatment (p = .01, ES = -.18).

Teri L, Logsdon RG, McCurry SM, et al. Gerontologist, 2020. PMID 30304477

2020 / Double-blind cross-over trial

Acute nicotinamide riboside supplementation improved redox markers and specific exercise performance outcomes in older, but not younger, men.

Twelve young and twelve old men received acute nicotinamide riboside (NR) or placebo in a double-blind cross-over study. NR supplementation increased NADH (51% young; 59% old) and NADPH (32% young; 38% old) in both groups, but only in older men did it decrease urine F2-isoprostanes by 18% (P < 0.05) and tend to raise glutathione (P = 0.078). In older individuals, NR improved isometric peak torque by 8% (P = 0.048) and the fatigue index by 15% (P = 0.012), while having no effect on VO2max, concentric peak torque, or physiological performance in young men.

Dolopikou CF, Kourtzidis IA, Margaritelis NV, et al. Eur J Nutr, 2020. PMID 30725213

2020 / Unblinded controlled pilot trial

Broccoli sprout capsules did not significantly alter 180-day survival in pancreatic cancer

Forty patients receiving palliative chemotherapy were placed unblinded into a treatment group (n = 29, receiving 15 daily capsules of pulverized broccoli sprouts) or placebo group (n = 11, receiving methylcellulose) for up to 1 year. The mean death rate was lower in the treatment group in the first 6 months (day 30: 0% vs 18%, day 90: 0% vs 25%, day 180: 25% vs 43%), but the endpoint at day 180 was not statistically significant (p = 0.291). Dropout rates after 1 year were high (72% treatment, 55% placebo). Taking 15 daily capsules was difficult for some patients, and the sprouts sometimes increased digestive problems, nausea, and emesis.

Lozanovski VJ, Polychronidis G, Gross W, et al. Invest New Drugs, 2020. PMID 31250356

2020 / Single-blinded randomized pilot study

In type 2 diabetes, 3 months of yoga and sham yoga yielded similar improvements, though yoga led to greater improvement in reduced glutathione.

Forty participants with type 2 diabetes mellitus were randomized to 3 months of either yoga (postures and breathing exercises, n = 20) or sham yoga (nonaerobic stretching, n = 20). Both groups demonstrated significant within-group improvements in malondialdehyde, vitamin C, superoxide dismutase, fasting blood glucose, glycosylated hemoglobin, body mass index, waist circumference, and blood pressure. Yoga participants showed significantly greater improvement in reduced glutathione compared to controls, but no other significant differences between groups were observed.

Hegde SV, Adhikari P, Kotian SM, et al. Int J Yoga Therap, 2020. PMID 31283365

2020 / Randomized controlled trial

Steamed onion capsule supplementation lowered body fat and triglycerides in overweight adults.

In a 12-week randomized, double-blind, placebo-controlled trial of 70 overweight adults, taking steamed onion capsules before each meal significantly decreased body fat percentage (p = 0.028) and total fat mass (p = 0.022) measured by DEXA. Computed tomography scans showed significant drops in visceral, subcutaneous, and whole fat areas at L1 and L4. Steamed onion intake also significantly reduced serum triglycerides and C-peptide levels without altering lean body mass.

Jeong S, Chae J, Lee G, et al. J Am Coll Nutr, 2020. PMID 31368861

2020 / Randomized controlled trial

Soursop juice lowered blood pressure and serum uric acid in a prehypertensive population.

In a randomized controlled trial, 143 subjects with essential prehypertension and high-normal serum uric acid (SUA) levels were assigned to receive 2 × 100 g soursop fruit juice daily or no treatment for 3 months. The soursop group showed significantly lower mean systolic blood pressure after adjustment across examinations, and the control group was more likely to have prehypertension, hypertension, and high-normal or high SUA levels at 6 and 12 weeks. In an analysis using 2017 ACC/AHA guidelines, both systolic and diastolic blood pressure were significantly lower in the treatment group than the control group after 12 weeks.

Alatas H, Sja'bani M, Mustofa M, et al. J Hum Hypertens, 2020. PMID 31462727

2020 / Pre-post intervention study

A 3-week whole-food plant-based education program for healthcare providers led to weight loss, improved mood and energy, and increased counseling likelihood.

An experiential education program was conducted with 30 nurse practitioners, registered nurses, and physicians who followed a whole-food plant-based (WFPB) diet for 3 weeks. Preintervention and postintervention questionnaires assessed various health and professional outcomes. Participants decreased their intake of animal-derived foods, increased WFPB food intake, lost weight, and experienced improvements in mood and energy. Additionally, perceived barriers to following and counseling about a WFPB diet declined, self-efficacy improved, and participants were likely to continue the diet and discuss it with patients.

Lessem A, Gould SM, Evans J, et al. J Am Assoc Nurse Pract, 2020. PMID 31577667

2020 / Topical application study and pilot nutrition intervention study

Oral intake of 100 mg pea sprout extract significantly reduced hair loss after 28 days in a pilot study of 21 volunteers.

A study evaluated the effects of pea sprout extract applied topically and consumed orally. In 10 volunteers, topical application of a fluid containing 2% pea sprout extract increased expression of FGF7 and noggin by 56% and 85%, respectively. In a subsequent pilot study of 21 volunteers, daily intake of 100 mg pea sprout extract (AnaGain™ Nu) for 8 weeks significantly reduced hair loss starting after 28 days of treatment (p < 0.002). No adverse events were reported.

Grothe T, Wandrey F, Schuerch C Phytother Res, 2020. PMID 31680356

2020 / Single-arm non-randomized trial

Single oral administration of up to 500 mg NMN was safe and effectively metabolized without significant deleterious effects in healthy men.

Ten healthy men received single oral doses of 100, 250, and 500 mg nicotinamide mononucleotide (NMN), with clinical parameters and NMN metabolite pharmacokinetics monitored for 5 hours after each intervention. The single oral doses caused no significant clinical symptoms or changes in heart rate, blood pressure, oxygen saturation, body temperature, ophthalmic examination, or sleep quality. Laboratory analyses showed increases in serum bilirubin and decreases in serum creatinine, chloride, and blood glucose within normal ranges, independent of dose. Plasma concentrations of N-methyl-2-pyridone-5-carboxamide and N-methyl-4-pyridone-5-carboxamide increased significantly in a dose-dependent manner.

Irie J, Inagaki E, Fujita M, et al. Endocr J, 2020. PMID 31685720

2020 / Randomized, placebo-controlled clinical trial

Nicotinamide riboside supplementation for 12 weeks did not alter skeletal muscle mitochondrial respiration, content, or morphology in obese, insulin-resistant men.

In a randomized, placebo-controlled trial, 40 middle-aged, obese, insulin-resistant men received 1000 mg nicotinamide riboside (NR) or placebo twice daily for 12 weeks. NR supplementation decreased NAMPT protein levels in skeletal muscle by 14%, but steady-state NAD+ levels and other biosynthetic enzymes were unchanged. NR did not affect skeletal muscle mitochondrial respiratory capacity, mitochondrial-associated protein abundance, mitochondrial fractional area, or network morphology.

Dollerup OL, Chubanava S, Agerholm M, et al. J Physiol, 2020. PMID 31710095

2020 / Randomized, placebo-controlled, 2x2 factorial trial and meta-analyses

In the VITAL trial, vitamin D3 supplementation did not reduce total cancer incidence or major CVD events, but showed a signal for reduced cancer mortality.

The VITAL trial evaluated daily vitamin D3 (2000 IU) and marine omega-3 fatty acids (1 g) over a median of 5.3 years in 25,871 older U.S. adults. Vitamin D did not significantly reduce total invasive cancer incidence (HR = 0.96 [95% CI 0.88-1.06]), major CVD events (HR = 0.97 [0.85-1.12]), or all-cause mortality (HR = 0.99 [0.87-1.12]). However, it showed a signal for reduced total cancer mortality (HR = 0.83 [0.67-1.02]), which was significant when excluding the first year (HR = 0.79 [0.63-0.99]) or first 2 years (HR = 0.75 [0.59-0.96]) of follow-up. Updated meta-analyses including VITAL and other trials indicated a significant reduction in cancer mortality, but not cancer incidence or CVD endpoints.

Manson JE, Bassuk SS, Buring JE, et al. J Steroid Biochem Mol Biol, 2020. PMID 31733345

2020 / 12-month double-blind randomized controlled trial

Whey-enriched protein supplementation did not improve physical performance or muscle measures in older adults with sarcopenia.

A 12-month randomized controlled trial evaluated 20 g twice daily whey-enriched protein supplementation versus an isocaloric placebo and a no-supplement control in 218 older people with sarcopenia, with all given instructions on home-based exercise, dietary protein, and vitamin D (20 μg/d). The supplements had no significant effect on physical performance; 12-month changes in short physical performance battery scores were -0.55, -0.05, and 0.03 points across control, isocaloric, and protein groups (P = .17), with similar changes in continuous summary physical performance scores (P = .76). Hand grip strength decreased significantly in all groups, calf muscle index showed no differences between groups, and post-trial follow-up found no differences in all-cause mortality or physical functioning. Mild gastrointestinal adverse effects were reported by 56% in both supplement groups.

Björkman MP, Suominen MH, Kautiainen H, et al. J Am Med Dir Assoc, 2020. PMID 31734121

2020 / Double-blind, randomized crossover trial

Intragastric quinine reduced postprandial glucose and stimulated insulin and GLP-1 without altering gastric emptying or energy intake in healthy men.

In two study parts, healthy lean men received intragastric quinine (275 mg or 600 mg) or control 30 minutes before a mixed-nutrient drink (part A, n=15) or a buffet meal (part B, n=12). Alone, both doses modestly stimulated insulin (P < 0.05). Following the drink, both quinine doses reduced plasma glucose and stimulated insulin (P < 0.05); 275 mg stimulated GLP-1 (P < 0.05), while 600 mg showed a trend toward stimulating GLP-1 (P = 0.066) and glucagon (P = 0.073). Quinine did not alter gastric emptying of the nutrient drink or subsequent buffet energy intake.

Bitarafan V, Fitzgerald PCE, Little TJ, et al. Am J Physiol Regul Integr Comp Physiol, 2020. PMID 31774306